Innovative BioDefense inks deal with Picketts Health to distribute Zylast antimicrobial product globally

LAKE FOREST, Calif. — Innovative BioDefense, manufacturer of the Zylast line of broad-spectrum, persistent antimicrobial products, on Tuesday announced an exclusive relationship with Australian-based Picketts Health to provide a modification of their proprietary lotion and antiseptic sanitizer for use in Picketts Health’s patented Orbel hand sanitizer applicator.  

“We are pleased Picketts Health has taken an important step towards solving the issue of compliance with the introduction of the Orbel,” stated Colette Cozean, Innovative BioDefense CEO. “Their choice in bringing Zylast in as the formulary shows their commitment to providing the premier antimicrobial solution.”  

The first markets Picketts Health plans to target are the United Kingdom, South Africa, Australia and China.  Zylast is protected by trademarks and patents pending in many countries worldwide.

The Orbel was designed to increase hand-hygiene compliance and help prevent the spread of bacteria, viruses and infections. Portable, with single-handed activation of a regulated dose, the Orbel’s multi-directional balls evenly facilitate distribution to all parts of the hands for increased protection.

Zylast has shown to kill 99.99% of most disease-causing germs in 15 seconds and is persistent for six hours, the company stated.